Process evaluation for biopharmaceuticals: what is appropriate in process evaluation?
Lubiniecki
A S
AS
SmithKline Beecham Pharmaceuticals, King of Prussia, PA, USA.
McAllister
P R
PR
Smith
T M
TM
Shadle
P J
PJ
D000818:Animals; D001688:Biological Products / Q000592:standards*; D016466:CHO Cells / Q000821:virology; D006224:Cricetinae; D004340:Drug Contamination / Q000517:prevention & control*; D049673:History, 20th Century; D006801:Humans; D015203:Reproducibility of Results; D012190:Retroviridae / Q000302:isolation & purification; D018570:Risk Assessment; D013242:Sterilization / Q000379:methods; D014765:Viral Vaccines / Q000009:adverse effects / Q000266:history*; D014771:Virion / Q000302:isolation & purification; D014777:Virus Diseases / Q000635:transmission*
D001688:Biological Products; D014765:Viral Vaccines